Compare Heron Therapeutics Inc (HRTX) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs UBS Group AG Registered Ordinary Shares — how do they compare? Heron Therapeutics Inc trades at $0.4 (market cap $68.01M), while UBS Group AG Registered Ordinary Shares trades at $47.81 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 2098.2× Heron Therapeutics Inc's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.34% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and UBS Group AG Registered Ordinary Shares for 0 Days on average.
| HRTX | UBS | |
|---|---|---|
Market Cap | $68.01M | $142.70B |
Volume | 1,891,941 | 2,096,090 |
Sector | Health | Financials |
52-Week High | $1.49 | $55.72 |
52-Week Low | $0.27 | $36.41 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $174.75M | $314.41B |
Dividend Yield | — | 2.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.
The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
